Pershing Seeks Court Ruling On Allergan Special Meeting
Pershing Square Capital Management LP has filed a lawsuit in Delaware court seeking a declaratory judgment to confirm that its recent push for a special meeting of Allergan, Inc. (NYSE:AGN) shareholders won’t trigger Allergan’s recently adopted poison pill.
The lawsuit, unveiled Friday, comes after a request Pershing made earlier this month to Allergan, Inc. (NYSE:AGN). The firm seeks confirmation that the company won't use its poison . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
|
